Trump admin seeks to severely limit all biotech interactions with China involving joint ventures, investments into US companies, and manufacturing.
My assessment of this action is different than yours. Let’s see how the market gages it next week.. Just the idea that the Trump administration would contemplate this type of action should send a shiver through the industry..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.